Elcin Ergun worked in senior global, regional and local leadership roles in pharma industry for more than 20 years including commercial, finance and innovation leadership.
Currently, she is president, new businesses, Merck Healthcare, based in Boston, in charge of a new entity carrying out external development and financing of several highly promising assets to create new businesses with estimated peak sales of 5-9 billion euro.
Prior to that, she was executive vice president, head of global commercial for Merck Serono based in Germany where she was responsible for a P&L of 4.5 billion euro and over 5,000 people, and achieved significant leadership and business transformation across global commercial operations.
In 2011-2012, she was senior vice president, head of intercontinental region of Merck Serono comprising of 69 countries across Middle East, Africa, Turkey, Russia/CIS with a P&L of 650 million Euro. During her term, topline grew by 40%. Prior to that, she was managing director of Turkey, where she started up and grew the operation to become a strong specialty player attaining market leadership in each key business.
In her earlier career, Elcin held several senior finance roles as CFO for SmithKline Beecham and as CFO for Honeywell where she was responsible for full spectrum of finance, accounting, treasury and reporting functions. She also spent one year in UK at Northern European HQ of Honeywell leading marketing and supply chain projects. She started her career as a software engineer and worked for ITT in Amsterdam for 5 years in IT management.
Elcin has a BSc degree in computer engineering from METU and an MBA from INSEAD, France.